Wikidata

(Q63578506)

English

A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC

clinical trial

In more languages

Statements

short name
MAGELLAN (English)
0 references
title
A Phase IB, Open-Label, Multi-Center Study to Determine the Efficacy and Safety of Durvalumab in Combination With Novel Oncology Therapies, With or Without Chemotherapy, for First-Line Stage IV Non Small Cell Lung Cancer (NSCLC) (MAGELLAN) (English)
0 references
sponsor
AstraZeneca
0 references
country
Austria
0 references
Belgium
0 references
Netherlands
0 references
Poland
0 references
Taiwan
0 references
Thailand
0 references
start time
27 December 2018
0 references
end time
25 December 2020
0 references
number of participants
200
0 references
research intervention
paclitaxel
0 references
cisplatin
0 references
gemcitabine
0 references
carboplatin
0 references
pemetrexed
0 references
durvalumab
0 references
minimum age
18 year
0 references
maximum age
130 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63578506&oldid=1857277946"